deltatrials
Completed PHASE1/PHASE2 INTERVENTIONAL 2-arm NCT01495598

Pomalidomide for Kaposi Sarcoma in People With or Without HIV

A Phase I/II Study of the Safety, Pharmacokinetics and Efficacy of Pomalidomide (CC-4047) in the Treatment of Kaposi Sarcoma in Individuals With or Without HIV

Sponsor: National Cancer Institute (NCI)

Interventions Pomalidomide
Updated 39 times since 2017 Last updated: Oct 5, 2022 Started: Jan 10, 2012 Primary completion: May 17, 2022 Completion: May 17, 2022
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT01495598, this PHASE1/PHASE2 trial focuses on Kaposi Sarcoma and Sarcoma, Kaposi and remains completed. Sponsored by National Cancer Institute (NCI), it has been updated 39 times since 2012, reflecting substantial change activity. This study contributes to the evolving evidence base for cancer treatment protocols.

Status Flow

~Jan 2017 – ~Feb 2017 · 31 days · monthly snapshot~Feb 2017 – ~Apr 2018 · 14 months · monthly snapshot~Apr 2018 – ~May 2018 · 30 days · monthly snapshot~May 2018 – ~Jun 2018 · 31 days · monthly snapshot~Jun 2018 – ~Jul 2018 · 30 days · monthly snapshot~Jul 2018 – ~Aug 2018 · 31 days · monthly snapshot~Aug 2018 – ~Apr 2019 · 8 months · monthly snapshot~Apr 2019 – ~May 2019 · 30 days · monthly snapshot~May 2019 – ~Jul 2019 · 2 months · monthly snapshot~Jul 2019 – ~Aug 2019 · 31 days · monthly snapshot~Aug 2019 – ~Nov 2019 · 3 months · monthly snapshot~Nov 2019 – ~Dec 2019 · 30 days · monthly snapshot~Dec 2019 – ~Jan 2020 · 31 days · monthly snapshot~Jan 2020 – ~Feb 2020 · 31 days · monthly snapshot~Feb 2020 – ~Mar 2020 · 29 days · monthly snapshot~Mar 2020 – ~May 2020 · 2 months · monthly snapshot~May 2020 – ~Jul 2020 · 2 months · monthly snapshot~Jul 2020 – ~Aug 2020 · 31 days · monthly snapshot~Aug 2020 – ~Oct 2020 · 2 months · monthly snapshot~Oct 2020 – ~Nov 2020 · 31 days · monthly snapshot~Nov 2020 – ~Jan 2021 · 2 months · monthly snapshot~Jan 2021 – ~Feb 2021 · 31 days · monthly snapshot~Feb 2021 – ~May 2021 · 3 months · monthly snapshot~May 2021 – ~Sep 2021 · 4 months · monthly snapshot~Sep 2021 – ~Oct 2021 · 30 days · monthly snapshot~Oct 2021 – ~Nov 2021 · 31 days · monthly snapshot~Nov 2021 – ~Dec 2021 · 30 days · monthly snapshot~Dec 2021 – ~Jan 2022 · 31 days · monthly snapshot~Jan 2022 – ~Feb 2022 · 31 days · monthly snapshot~Feb 2022 – ~Mar 2022 · 28 days · monthly snapshot~Mar 2022 – ~Apr 2022 · 31 days · monthly snapshot~Apr 2022 – ~May 2022 · 30 days · monthly snapshot~May 2022 – ~Jun 2022 · 31 days · monthly snapshot~Jun 2022 – ~Jul 2022 · 30 days · monthly snapshot~Jul 2022 – ~Sep 2022 · 2 months · monthly snapshot~Sep 2022 – ~Dec 2022 · 3 months · monthly snapshot~Dec 2022 – ~Jul 2024 · 19 months · monthly snapshot~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshot~Sep 2024 – present · 22 months · monthly snapshot

Change History

39 versions recorded
  1. Sep 2024 — Present [monthly]

    Completed PHASE1/PHASE2

  2. Jul 2024 — Sep 2024 [monthly]

    Completed PHASE1/PHASE2

    Phase: PHASE1_PHASE2PHASE1/PHASE2

  3. Dec 2022 — Jul 2024 [monthly]

    Completed PHASE1_PHASE2

  4. Sep 2022 — Dec 2022 [monthly]

    Completed PHASE1_PHASE2

  5. Jul 2022 — Sep 2022 [monthly]

    Completed PHASE1_PHASE2

Show 34 earlier versions
  1. Jun 2022 — Jul 2022 [monthly]

    Completed PHASE1_PHASE2

    Status: Active Not RecruitingCompleted

  2. May 2022 — Jun 2022 [monthly]

    Active Not Recruiting PHASE1_PHASE2

  3. Apr 2022 — May 2022 [monthly]

    Active Not Recruiting PHASE1_PHASE2

  4. Mar 2022 — Apr 2022 [monthly]

    Active Not Recruiting PHASE1_PHASE2

  5. Feb 2022 — Mar 2022 [monthly]

    Active Not Recruiting PHASE1_PHASE2

  6. Jan 2022 — Feb 2022 [monthly]

    Active Not Recruiting PHASE1_PHASE2

  7. Dec 2021 — Jan 2022 [monthly]

    Active Not Recruiting PHASE1_PHASE2

  8. Nov 2021 — Dec 2021 [monthly]

    Active Not Recruiting PHASE1_PHASE2

  9. Oct 2021 — Nov 2021 [monthly]

    Active Not Recruiting PHASE1_PHASE2

  10. Sep 2021 — Oct 2021 [monthly]

    Active Not Recruiting PHASE1_PHASE2

  11. May 2021 — Sep 2021 [monthly]

    Active Not Recruiting PHASE1_PHASE2

  12. Feb 2021 — May 2021 [monthly]

    Active Not Recruiting PHASE1_PHASE2

  13. Jan 2021 — Feb 2021 [monthly]

    Active Not Recruiting PHASE1_PHASE2

  14. Nov 2020 — Jan 2021 [monthly]

    Active Not Recruiting PHASE1_PHASE2

  15. Oct 2020 — Nov 2020 [monthly]

    Active Not Recruiting PHASE1_PHASE2

  16. Aug 2020 — Oct 2020 [monthly]

    Active Not Recruiting PHASE1_PHASE2

  17. Jul 2020 — Aug 2020 [monthly]

    Active Not Recruiting PHASE1_PHASE2

  18. May 2020 — Jul 2020 [monthly]

    Active Not Recruiting PHASE1_PHASE2

  19. Mar 2020 — May 2020 [monthly]

    Active Not Recruiting PHASE1_PHASE2

  20. Feb 2020 — Mar 2020 [monthly]

    Active Not Recruiting PHASE1_PHASE2

  21. Jan 2020 — Feb 2020 [monthly]

    Active Not Recruiting PHASE1_PHASE2

  22. Dec 2019 — Jan 2020 [monthly]

    Active Not Recruiting PHASE1_PHASE2

  23. Nov 2019 — Dec 2019 [monthly]

    Active Not Recruiting PHASE1_PHASE2

  24. Aug 2019 — Nov 2019 [monthly]

    Active Not Recruiting PHASE1_PHASE2

  25. Jul 2019 — Aug 2019 [monthly]

    Active Not Recruiting PHASE1_PHASE2

  26. May 2019 — Jul 2019 [monthly]

    Active Not Recruiting PHASE1_PHASE2

  27. Apr 2019 — May 2019 [monthly]

    Active Not Recruiting PHASE1_PHASE2

  28. Aug 2018 — Apr 2019 [monthly]

    Active Not Recruiting PHASE1_PHASE2

  29. Jul 2018 — Aug 2018 [monthly]

    Active Not Recruiting PHASE1_PHASE2

  30. Jun 2018 — Jul 2018 [monthly]

    Active Not Recruiting PHASE1_PHASE2

  31. May 2018 — Jun 2018 [monthly]

    Active Not Recruiting PHASE1_PHASE2

  32. Apr 2018 — May 2018 [monthly]

    Active Not Recruiting PHASE1_PHASE2

    Status: RecruitingActive Not Recruiting

  33. Feb 2017 — Apr 2018 [monthly]

    Recruiting PHASE1_PHASE2

  34. Jan 2017 — Feb 2017 [monthly]

    Recruiting PHASE1_PHASE2

    First recorded

Jan 2012

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • National Cancer Institute (NCI)
Data source: National Institutes of Health Clinical Center (CC)

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations